布鲁氏菌外膜囊泡经肌内、皮下和鼻内免疫途径在小鼠中具有可比保护效力
本研究以布鲁氏菌M5株外膜囊泡(OMVs-M5)免疫小鼠,比较肌内、皮下和鼻内三种途径的保护效果。三种途径均诱导强效体液免疫和CD4+ T细胞免疫,对强毒布鲁氏菌攻击提供可比保护,表现为脾脏细菌载量显著降低和病理损伤减轻。
要点
- OMVs-M5经肌内、皮下、鼻内免疫均诱导强效体液免疫和CD4+ T细胞免疫。
- 三种途径对强毒布鲁氏菌攻击均提供可比保护,脾脏细菌载量显著降低、病理损伤减轻。
- 肌内和皮下注射初期引起严重反应原性,鼻内给药未引起。
核心结论
- 肌内、鼻内或皮下递送OMVs-M5均能有效保护小鼠抵抗布鲁氏菌感染,各途径间未观察到主要差异。
研究设计与样本
- 研究用布鲁氏菌M5株来源的外膜囊泡(OMVs-M5)免疫小鼠,比较肌内、皮下和鼻内三种免疫途径,并以强毒布鲁氏菌株攻击。
主要发现
- OMVs-M5在离体实验中呈现弱的先天免疫激活且无细胞毒性。
- 肌内或皮下注射OMVs-M5的小鼠在初始数天出现严重反应原性,鼻内给药未出现。
- 肌内、鼻内或皮下免疫OMVs-M5的小鼠对强毒布鲁氏菌攻击呈现可比保护效力,脾脏细菌载量显著降低、组织病理损伤较轻。
- 三种免疫途径均诱导强效体液免疫和CD4+ T细胞介导的免疫应答。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brucella melitensis is a causative agent of chronic infection in both animals and humans. Immunization with outer membrane vesicles (OMVs) released from B. melitensis has been shown to significantly reduce disease burden. This study aimed to investigate the effect of different immunization routes on effect protective immunity conferred by B. melitensis OMVs. OMVs derived from B. melitensis M5 (OMVs-M5) exhibited weak activation of innate immunity and no cytotoxicity in ex vivo assays. Immunization with OMVs-M5 via intramuscular or subcutaneous injection induced severe reactogenicity in mice during the initial days, whereas intranasal administration did not. Mice immunized intramuscularly, intranasally, or subcutaneously with OMVs-M5 showed comparable protective efficacy against challenge with a virulent B. melitensis strain, characterized by significantly reduced bacterial burdens and milder histopathological lesions in the spleen. All three routes of immunization elicited robust humoral immunity and CD4+ T cell-mediated immune responses. These findings provide experimental evidence that intramuscular, intranasal or subcutaneous delivery of OMVs-M5 are all effective in protecting mice against B. melitensis infection, with no major differences observed between routes.
引用
- Huang Y, Li T, Zhang Y, et al. Comparable protective efficacy of Brucella melitensis outer membrane vesicles via intramuscular, subcutaneous, and intranasal immunization routes in mice. Vaccine. 2025. PMID: 41207070. doi:10.1016/j.vaccine.2025.127963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。